ASMB logo
ASMB NASDAQ US

Assembly Biosciences, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Dec 2010
$29.01
▼ $-0.42 (-1.43%)
Vol 38K
5
Quality Score
fail
Mkt Cap
$537.9M
ROE
-59.0%
Margin
-103.7%
D/E
0.00
Beta
1.13
52W
$8–$40

Wall Street Consensus

10 analysts · Apr 2026
4
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
90.0%
Buy Rating

Price Chart

Similar Stocks

VSTM
Verastem Inc
$581.5M
LYEL
Lyell Immunopharma Inc
$653.9M
FDMT
4D Molecular Therapeutics Inc
$428.5M
IMMX
Immix Biopharma Inc
$275.6M
ABSI
Absci Corp
$524.8M
STTK
Shattuck Labs Inc
$231.0M
MYGN
Myriad Genetics Inc
$573.3M
RGNX
Regenxbio Inc
$729.0M
ALT
Altimmune Inc
$376.7M

Earnings

Beat rate: 100.0%
Next Report May 06, 2026
EPS Estimate: $-0.61
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.61 — —
Dec 2025 $-0.66 $2.48 +$3.14
Sep 2025 $-0.79 $-0.72 +$0.07
Jun 2025 $-1.39 $-1.33 +$0.06

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -149.0% -149.0% -149.0% -149.0% -149.0% -59.0%
P/E (TTM) — — — — — —
Net Margin -105.9% -117.2% -117.2% -117.2% -117.2% -103.7%
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 1.64 1.64 1.64 1.64 1.64 4.44

Key Ratios

ROA (TTM)
-28.6%
P/S (TTM)
14.46
P/B
3.0
EPS (TTM)
$-4.81
CF/Share
$-1.41
Rev Growth 3Y
+65.8%
52W High
$39.71
52W Low
$7.75
$7.75 52-Week Range $39.71

How does ASMB compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

ASMB AAPG ABEO ABOS ABP

ASMB valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
14.5
▲ 13% above peers (12.9)
vs Peers
vs Industry
Fair value
P/B ratio
3.0
▲ 22% above peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

ASMB profitability vs Biotechnology peers

ROE
-59.0%
▲ 12% above peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
-103.7%
▲ 64% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-28.6%
▲ 39% above peers (-46.7%)
vs Peers
vs Industry
Below avg

ASMB financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
4.4
▼ 0% below peers (4.4)
vs Peers
vs Industry
In line
Beta
1.1
▲ 17% above peers (1.0)
vs Peers
vs Industry
More volatile

ASMB fundamentals radar

ASMB Peer median Industry

ASMB profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ASMB vs peers: key metrics

Latest News

No related news yet